These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18810243)

  • 1. Effect of cannabinoid receptor agonists on streptozotocin-induced hyperalgesia in diabetic neuropathy.
    Bujalska M
    Pharmacology; 2008; 82(3):193-200. PubMed ID: 18810243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy.
    Bujalska-Zadrożny M; de Cordé A; Pawlik K
    Pharmacol Rep; 2015 Apr; 67(2):209-16. PubMed ID: 25712641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice.
    Ikeda H; Ikegami M; Kai M; Ohsawa M; Kamei J
    Neuroscience; 2013 Oct; 250():446-54. PubMed ID: 23892011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.
    Gutierrez T; Farthing JN; Zvonok AM; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Jan; 150(2):153-63. PubMed ID: 17160008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
    Burgos E; Gómez-Nicola D; Pascual D; Martín MI; Nieto-Sampedro M; Goicoechea C
    Eur J Pharmacol; 2012 May; 682(1-3):62-72. PubMed ID: 22374260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.
    Scutt A; Williamson EM
    Calcif Tissue Int; 2007 Jan; 80(1):50-9. PubMed ID: 17205329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.
    Ahmed MM; Rajpal S; Sweeney C; Gerovac TA; Allcock B; McChesney S; Patel AU; Tilghman JI; Miranpuri GS; Resnick DK
    Spine J; 2010 Dec; 10(12):1049-54. PubMed ID: 20920894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin receptors antagonists and nitric oxide synthase inhibitors in vincristine and streptozotocin induced hyperalgesia in chemotherapy and diabetic neuropathy rat model.
    Bujalska M; Makulska-Nowak H
    Neuro Endocrinol Lett; 2009 Mar; 30(1):144-52. PubMed ID: 19300402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model.
    Cui JH; Kim WM; Lee HG; Kim YO; Kim CM; Yoon MH
    Neurosci Lett; 2011 Apr; 493(3):67-71. PubMed ID: 21195743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain.
    Zhu CZ; Mikusa JP; Fan Y; Hollingsworth PR; Pai M; Chandran P; Daza AV; Yao BB; Dart MJ; Meyer MD; Decker MW; Hsieh GC; Honore P
    Br J Pharmacol; 2009 Jun; 157(4):645-55. PubMed ID: 19371344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
    Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
    Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain.
    Khasabova IA; Gielissen J; Chandiramani A; Harding-Rose C; Odeh DA; Simone DA; Seybold VS
    Behav Pharmacol; 2011 Sep; 22(5-6):607-16. PubMed ID: 21610490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.
    Hama A; Sagen J
    Brain Res; 2011 Sep; 1412():44-54. PubMed ID: 21813113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes.
    Nieri P; Greco R; Adinolfi B; Breschi MC; Martinotti E; Nannetti C; Podestà A
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):352-9. PubMed ID: 14566452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
    Johanek LM; Simone DA
    Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.
    Toth CC; Jedrzejewski NM; Ellis CL; Frey WH
    Mol Pain; 2010 Mar; 6():16. PubMed ID: 20236533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
    Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
    Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers.
    Bingham B; Jones PG; Uveges AJ; Kotnis S; Lu P; Smith VA; Sun SC; Resnick L; Chlenov M; He Y; Strassle BW; Cummons TA; Piesla MJ; Harrison JE; Whiteside GT; Kennedy JD
    Br J Pharmacol; 2007 Aug; 151(7):1061-70. PubMed ID: 17549048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
    Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
    Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.